Article
Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
Journal of drug targeting - 1 May 2014
Wang Yuan, Tian Zehua, Thirumalai Diraviyam, Zhang Xiaoying
Abstract excerpt
The biomedical applications of antibodies as prophylactics, therapeutics and diagnostics are developing rapidly. Neonatal Fc receptor (FcRn) is a major IgG Fc receptor capable of facilitating the translocation of IgG. FcRn can protect IgG from intracellular catabolism, thereby increasing its half-life. In recent decade, the interaction between FcRn and the Fc region has been reported with the focuses on either...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
